Mounjaro - Newly approved medication for Type 2 Diabetes Treatment
Mounjaro, known generically as Tirzepatide, is a medication used primarily for the treatment of type 2 diabetes in adults. It is developed and manufactured by Eli Lilly and Company, was FDA-approved on May 13, 2022, specifically for improving blood sugar levels in adults with type 2 diabetes. The comprehensive data from its clinical trials and ... Read more